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To the Editor, 
Food protein-induced enterocolitis syndrome (FPIES) is an uncommon, non-
immunoglobulin E (IgE)-mediated food allergy that usually occurs in young infants (1). 
Patients with FPIES exhibit profuse vomiting, lethargy, pallor and diarrhea, which 
typically occur 1 to 4 h after the ingestion of the causative food. The most common 
causative foods are cow’s milk and soy. FPIES is usually diagnosed based on medical 
history, response to an elimination diet, and an oral food challenge. An oral food 
challenge remains the gold standard test for all food allergies including FPIES, although 
it carries a risk for life-threatening reactions.  
Skin-prick test and specific IgE have been reported to be negative in the majority 
of patients with FPIES at diagnosis (1). Diagnostic value of atopy patch testing remains 
unclear, although patients with FPIES may show positive patch tests with the specific 
allergen (1). A frequent sensitization to causative foods can also be demonstrated by 
lymphocyte stimulation tests, although there is some controversy over their usefulness (1). 
Moreover, little is known about dynamic changes in biomarkers reflecting acute FPIES 
reactions. Leukocytosis and thrombocytosis have been reported in the acute phase, and 
the former is included in the diagnostic criteria proposed by Powell (2). These increases 
likely occur as a result of the secretion of humoral factors including inflammatory 
cytokines, and may not be specific for FPIES. We therefore investigated changes in fecal 
markers that could directly reflect gastrointestinal events in acute FPIES reactions. 
We studied eight Japanese patients affected with FPIES (Table 1). The diagnosis 
of FPIES was based on the previously established criteria: 1) repeated exposure to the 
incriminated food elicits repetitive vomiting and/or diarrhea within 24 h, without any 
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other cause for the symptoms; 2) symptoms are limited to the gastrointestinal tract; and 3) 
removal of the offending protein from the diet results in resolution of symptoms and/or a 
food challenge elicits vomiting and/or diarrhea within 24 h after administration of the 
food (3-5). After making a suspected diagnosis of FPIES, trigger foods were eliminated 
in all patients. We performed an oral food challenge test in six patients (P1 to P6) in the 
hospital according to the guideline by Powell et al. (2) and the Japanese guideline for 
food allergy with minor modifications (6). Briefly, an intravenous line was established 
before challenge, and oxygen saturation and heart rate were monitored during the 
procedure. Patients were given the same amount of trigger food that caused the reactions 
or up to 0.6 g protein/kg body weight. The diagnostic food challenge test was avoided in 
patients P7 and P8, both of whom had more than three episodes of the typical reactions. 
Approval for the study was obtained from the Human Research Committee of Kanazawa 
University Graduate School of Medical Science, and informed consent was provided 
according to the Declaration of Helsinki. 
Fecal samples were collected from patients P1 to P6 before and after the food 
challenge test. In patients P7 and P8, samples were first collected at their initial visit to 
our hospital. While planning the challenge test, another episode of FPIES provided us 
with their fecal samples after accidental ingestion of the causative food. If patients had no 
spontaneous passage of stool on the next day after the ingestion, glycerin enemas were 
given. Fecal samples were collected at each defecation during the next 1 to 2 days. 
Control samples were obtained from 12 age-matched healthy infants. Feces were 
weighted and diluted 3 to 10 times with phosphate-buffered saline immediately after 
sample collection or after thawing frozen samples. Homogenization was performed using 
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a paddle blender (Interscience, St Nom, France) for 20 min. After centrifugation at 20000 
g for 10 min, supernatants were collected and stored at -20°C until assay. Concentrations 
of biomarkers were determined using commercially available enzyme-linked 
immunosorbent assay kits for EDN (MBL, Nagoya, Japan) and calprotectin 
(Immundiagnostik, Bensheim, Germany). IgA levels were measured by a standard 
sandwich enzyme-linked immunosorbent assay (7).  
The mean age of onset was 5.4 ± 3.5 mo, and the mean time to diagnosis was 3.0 
± 2.1 mo. The common symptoms were vomiting (8/8), diarrhea (3/8), and lethargy (3/8). 
Most patients (7/8) developed symptoms 2 h after the ingestion. All 6 of the patients who 
underwent the food challenge test exhibited typical reactions of FPIES, which did not 
differ from their medical history derived from the accidental ingestion of the causative 
food. Time to symptoms during the challenge test was also similar to those of the 
accidental ingestion of the causative food in these patients. Consistent with previous 
reports (1), cow’s milk was the most common causative food, followed by wheat. All of 
our patients reacted to a single food. Two patients (P2 and P6) exhibited positive, albeit 
low titer, specific IgE results for the causative food (cow’s milk); however, no patients 
had experienced IgE-mediated acute symptoms such as urticaria and wheezing. After 
elimination of the causative food, no episodes of FPIES were noted in any patient. 
Before oral food challenges, mild elevation of fecal EDN levels was observed in 3 
of 8 patients. However, these patients did not necessarily show high concentrations of 
fecal calprotectin and IgA at the same time (Fig 1A). There was no correlation between 
time to diagnosis and baseline elevations of fecal markers in our patients. In contrast, a 
significant increase in fecal EDN after ingestion of the causative food was demonstrated 
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in all patients (mean, 33244 ng/mL; Fig 1A). The median time to maximum concentration 
of fecal EDN was 23.5 h. The levels of fecal calprotectin and IgA were also increased; 
however, they were much lower than those of EDN (Fig 1B).  
The level of EDN was increased a half-day after ingestion and reached the 
maximum around 24 h later (Fig 1C). Of note, the elevation of fecal EDN was observed 
even in non-diarrheal stool specimens. These findings are in line with the Powell’s 
criteria, in which cells and eosinophilic debris are absent in baseline stool smear and 
present as early as 6 h after oral food challenges, or as late as the next day (2). Such 
kinetics may simply reflect intestinal transit time of stool. Accordingly, the levels of fecal 
EDN may not be sufficiently elevated in samples collected just after ingesting the 
causative food or at an acute FPIES reaction. On the other hand, levels of fecal EDN 
before oral food challenges were variable in our patients, which was consistent with a 
previous report (8). Increased levels of baseline fecal EDN in some patients may be 
attributable to a direct consequence of previous FPIES episodes or non-specific intestinal 
inflammation due to previous FPIES episodes. Importantly, such patients also exhibited a 
further increase in fecal EDN after ingesting the causative food. Taken together, these 
findings suggest that serial analysis of fecal EDN after ingesting the causative food may 
serve as a useful diagnostic marker of FPIES. This approach can be used even after 
accidental ingestion of the causative food in both out-of-hospital and hospital settings. 
Nevertheless, as this study cohort is small, larger studies will be required to confirm our 
observations. 
Accumulation of eosinophils has been found in intestinal biopsies from patients 
with FPIES. However, it has been also described in other gastrointestinal disorders such 
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as eosinophilic gastroenteropathies, and eosinophils are a normal component of intestinal 
mucosal tissue. EDN, one of the four major eosinophil granule proteins, is recognized as 
being involved in antiviral host defense. Neutrophils have been found in stool mucus 
from patients with FPIES (2). In fact, our patients exhibited increased levels of fecal 
calprotectin after ingestion of the causative food, albeit at lower levels than fecal EDN. 
Phagocytes are the main source of fecal calprotectin, which has been reported to be a 
reliable marker of inflammatory activity in inflammatory bowel diseases (9). These 
findings suggest that the elevations of fecal EDN and calprotectin are not specific for 
FPIES. However, dynamic changes in fecal EDN after ingesting the causative food could 
distinguish FPIES from other inflammatory conditions. In addition, the changes may 
point to a characteristic component of the immune reaction in FPIES, and provide us an 
additional tool for evaluating FPIES reactions. Although FPIES is considered to be a T-
cell mediated disorder, its immune mechanisms remain to be determined. A recent study 
has shown that antigen-specific T-cell responses are predominantly skewed to Th2 in 
FPIES (10). Thus, further studies will be necessary to elucidate a link between antigen-
specific T-cell responses and inflammatory responses including eosinophil activation in 
FPIES. 
 In summary, our studies demonstrate a significant elevation of fecal EDN after the 
ingestion of causative foods and may offer additional perspective on the diagnosis of 
FPIES. Characterization of fecal markers that reflect inflammatory gastrointestinal 
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Table 1  Patient characteristics 
 P1 P2 P3 P4 P5 P6 P7 P8 
 
Age at onset (mo) 10 0 7 7 6 0 6 7 
Age at diagnosis (mo) a 16 1 13 11 8 1 8 9 
Sex F F M M F F M F 
Trigger food Fish b CM Egg Wheat Rice CM CM Wheat 
Symptoms Vomiting Vomiting Vomiting Vomiting Vomiting Failure Vomiting Vomiting 
 Lethargy Pallor Lethargy lethargy diarrhea to thrive Bloody Pallor 
  Fever Diarrhea   Vomiting stool Diarrhea 
      Bloody 
      stool 
Time to symptoms (h) 2 2 2 2 2 8 2 2 
Total IgE (IU/mL) 5 60 5 28 22 15 42 111 
Specific IgE c fish (0) β-LG (2) egg (0) egg (3) egg (2) milk (1) milk (0) egg (1) 
  milk (1)  wheat (0) rice (0)  casein (0) wheat (0) 
  casein (1)  gluten (0)   β-LG (0) gluten (0) 
 
CM, cow’s milk; β-LG, β-lactoglobulin. a Age of confirmed diagnosis by the challenge test (P1 to P6) or by clinical assessment (P7 





Figure 1  Analysis of eosinophil-derived neurotoxin (EDN), calprotectin and IgA. A, 
Fecal markers were measured in patients with FPIES before and after the ingestion of the 
causative food. Shaded areas represent the ranges of the normal values. B, Ratio between 
before and after the ingestion. C, Kinetics of fecal EDN. Analysis of differences among 
groups was performed using the Student’s t-test and differences with p-values less than 
0.05 were considered significant. ns, not significant. *p < 0.05; **p < 0.01; ***p < 0.001. 
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